A Comparison of the Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs versus Acetaminophen in Symptom Relief for the Common Cold: A Meta-Analysis of Randomized Controlled Trial Studies
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for common cold symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in common cold symptom relief using meta-analysis of randomized controlled trial. Methods: We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. Results: We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I2 = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77to 1.35) and I2 = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I2 = 0%. There was no apparent asymmetry in the funnel plot. Conclusion: There was no difference between NSAIDs and acetaminophen in common cold symptom relief.
Abstract
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are widely used for common cold symptom relief. The objective of this study was to evaluate and compare the efficacy and safety of acetaminophen and NSAIDs in common cold symptom relief using meta-analysis of randomized controlled trial. Methods: We searched MEDLINE (PubMed), Cochrane, EMBASE, CINAHL, KMbase, KoreaMed, National Assembly Library, and Riss4u for studies released through June 2012. Two authors independently extracted the data. To assess the risk of bias, the Cochrane Collaborations risk of bias tool was used. The Review Manager ver. 5.1 (RevMan) was used for statistics. Results: We identified 5 studies. The relative benefit for participants with pain relief was 1.00 (95% confidence interval [CI], 0.96 to 1.05) and I2 = 0%. The existence of the heterogeneity between studies was not important in this study, thus subgroup analysis was not implemented. The relative benefit for participants with rhinorrhea was 1.02 (95% CI, 0.77to 1.35) and I2 = 0%, which also indicates the existence of heterogeneity was not important. The relative risk of adverse events was 1.14 (95% CI, 0.93 to 1.40), I2 = 0%. There was no apparent asymmetry in the funnel plot. Conclusion: There was no difference between NSAIDs and acetaminophen in common cold symptom relief.
참고문헌 (22)
- Heikkinen T, "The common cold", Lancet, 361, pp.51~59 (2003)
- Taverner D, "Nasal decongestants for the common cold", Cochrane Database Syst Rev, (1), pp.CD001953~ (2007)
- Treanor JJ, "Viral infections, In Textbook of respiratory medicine", pp.870~872 (2005), Saunders
- Desmond RA, "Enteroviral meningitis: natural history and outcome of pleconaril therapy", Antimicrob Agents Chemother, 50, pp.2409~2414 (2006)
- Kim SY, "Nonsteroidal anti-inflammatory drugs for the common cold", Cochrane Database Syst Rev, (3), pp.CD006362~ (2009)
- Tan T, "Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance", BMJ, 337, pp.a437~ (2008)
- Schachtel BP, "Sore throat pain in the evaluation of mild analgesics", Clin Pharmacol Ther, 44, pp.704~711 (1988)
- Migliardi JR, "Caffeine as an analgesic adjuvant in tension headache", Clin Pharmacol Ther, 56, pp.576~586 (1994)
- Bachert C, "Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, doubledummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study", Clin Ther, 27, pp.993~1003 (2005)
- Juni P, "Risk of cardiovascular events and rofecoxib: cumulative meta-analysis", Lancet, 364, pp.2021~2029 (2004)
- Aldington S, "Increased risk of cardiovascular events with parecoxib", valdecoxib: a systematic review and meta-analysis, 2005, pp.118, U1755~
- Aw TJ, "Meta-analysis of cyclooxygenase- 2 inhibitors and their effects on blood pressure", Arch Intern Med, 165, pp.490~496 (2005)
- Lanas A, "Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds: gastrointestinal adverse effects: a metaanalysis of randomized clinical trials", Drugs R D, 11, pp.277~288 (2011)
- "Assessing risk of bias in included studies" (2011)[URL]
- Cochrane Collaboration, "Review manager (RevMan)" (2011), The Nordic Cochrane Centre
- "Analysing data and undertaking metaanalysis" (2011)[URL]
- Moore N, "Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain", Int J Clin Pract, 56, pp.732~734 (2002)
- Ulukol B, "Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections", Eur J Clin Pharmacol, 55, pp.615~618 (1999)
- Ugazio AG, "Clinical and pharmacokinetic study of nimesulide in children", Drugs, 46(Suppl 1), pp.215~218 (1993)
- Graham NM, "Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers", J Infect Dis, 162, pp.1277~1282 (1990)
- Phadke MA, "Ibuprofen in children with infective disorders: antipyretic efficacy", Br J Clin Pract, 39, pp.437~440 (1985)
- 윤여정, "A Comparison of Efficacy and Safety of Nonsteroidal Anti-inflammatory Drugs versus Acetaminophen in the Treatment of Episodic Tension-type Headache: A Meta-analysis of Randomized Placebo-controlled Trial Studies", Korean Journal of Family Medicine, 33(5), pp.262~271 (2012), 대한가정의학회